Ordaos
New York, NY, United States · ordaos.bio
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Ordaos designs de novo mini-proteins and single domain antibodies for drug discovery and therapeutic development. It works with pharma and biotech partners to create novel candidates from its base in New York, USA.
Their website has a general contact form; we send your quote request through it.
What they offer
De novo mini-protein design
Creates novel mini-proteins from scratch using its Design Engine and AI-driven sequence and structure generation.
Single domain antibody optimization
Optimizes single domain VHH antibodies for target binding and developability using generative AI.
Therapeutic candidate design for target profiles
Translates human-defined molecular target product profiles into designed miniPRO candidates.
What they work on
- Modalities
- Antibody, Peptide
- Assays and studies
- binding specificity, binding affinity, solubility, stability, immunogenicity, developability
- Therapeutic areas
- drug discovery, therapeutics
- Turnaround
- within weeks
- Sites
- New York, USA
- Address
- 228 Park Ave S 60684, New York, NY 10003, USA
Similar labs. Bioneeds, Capralogics, Creative Biolabs, Ribopro
Found in a contract services directory. Listing built from ordaos.bio. Work here? Claim this listing.